Q2 2019 13F Holders as of 30 Jun 2019
-
Type / Class
-
Equity / COM
-
Total 13F shares
-
24,571,761
-
Share change
-
+57,182
-
Total reported value
-
$121,537,224
-
Put/Call ratio
-
36%
-
Price per share
-
$4.95
-
Number of holders
-
78
-
Value change
-
+$164,185
-
Number of buys
-
34
-
Number of sells
-
34
Institutional Holders of JOUNCE THERAPEUTICS INC - COM (JNCE) as of Q2 2019
As of 30 Jun 2019,
JOUNCE THERAPEUTICS INC - COM (JNCE) was held by
78 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
24,571,761 shares.
The largest 10 holders included
TRV GP II, LLC, TRV GP III, LLC, WELLINGTON MANAGEMENT GROUP LLP, BlackRock Inc., FMR LLC, VANGUARD GROUP INC, DIMENSIONAL FUND ADVISORS LP, Erste Asset Management GmbH, Omega Fund Management, LLC, and ACADIAN ASSET MANAGEMENT LLC.
This page lists
78
institutional shareholders reporting positions in this security
for the Q2 2019 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.